Table 1. Baseline characteristics of patients in the Lira and Met groups.
| Term | Lira group (n=52) | Met group (n=75) | t | P |
|---|---|---|---|---|
| Age (year) | 58.5 ± 7.6 | 56.4 ± 8.4 | −1.68 | 0.10 |
| Gender ratio (male/female) | 31/21 | 43/32 | 0.018 | 0.89 |
| SBP (mmHg) | 140 ± 20 | 138 ± 16 | −0.072 | 0.943 |
| DBP (mmHg) | 91 ± 13.6 | 84 ± 12.6 | −0.712 | 0.481 |
| Weight (kg) | 66.91 ± 10.03 | 66.27 ± 10.00 | 0.062 | 0.951 |
| BMI (kg/m2) | 28.18 ± 1.86 | 27.61 ± 1.77 | 1.58 | 0.12 |
| TC (mmol/l) | 5.03 ± 0.97 | 5.15 ± 0.92 | −0.62 | 0.54 |
| TG (mmol/l) | 2.47 ± 1.49 | 2.51 ± 1.73 | −1.01 | 0.32 |
| LDL (mmol/l) | 2.56 ± 0.83 | 2.62 ± 0.82 | −1.57 | 0.12 |
| HDL (mmol/l) | 1.05 ± 0.24 | 0.99 ± 0.20 | 1.34 | 0.18 |
| ALT (U/l) | 65.74 ± 18.13 | 65.81 ± 17.58 | −0.02 | 0.99 |
| AST (U/l) | 35.96 ± 12.27 | 34.28 ± 13.69 | 0.62 | 0.54 |
| AST/ALT | 0.60 ± 0.06 | 0.60 ± 0.05 | 0.05 | 0.96 |
| FPG (mmol/l) | 8.45 ± 0.64 | 8.41 ± 0.69 | 0.34 | 0.73 |
| 2hPG (mmol/l) | 15.09 ± 5.42 | 14.64 ± 5.12 | 0.81 | 0.42 |
| HbA1C (%) | 8.14 ± 0.51 | 8.09 ± 0.59 | −0.86 | 0.59 |
| HOMA-IR | 3.05 ± 0.55 | 2.94 ± 0.59 | 0.95 | 0.34 |
| APN (mg/l) | 8.43 ± 1.01 | 8.13 ± 1.23 | 1.27 | 0.21 |
| CRP | 3.14 ± 0.58 | 3.16 ± 0.68 | −0.18 | 0.86 |
| CK18 (IU/l) | 284.03 ± 45.67 | 293.15 ± 38.55 | 1.26 | 0.23 |
Abbreviation: CK18, cytokeratin 18.